Invention Grant
- Patent Title: Fused bicyclic imidazoles
-
Application No.: US14090367Application Date: 2013-11-26
-
Publication No.: US09387204B2Publication Date: 2016-07-12
- Inventor: Swen Hölder , Armin Zülch , Thomas Bär , Thomas Maier , Astrid Zimmermann , Thomas Beckers , Volker Gekeler , Hemant Joshi , Yogesh Munot , Umesh Bhise , Sunil Chavan , Sachin Shivatare , Sarvesh Patel , Vikas Gore
- Applicant: BAYER INTELLECTUAL PROPERTY GmbH
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: IN1573/MUM/2007 20070814; EP07118733 20071018
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D401/10 ; A61K31/519 ; A61P35/00 ; A61K31/454 ; C07D471/04 ; C07D498/04 ; C07D513/04 ; A61K31/4545 ; A61K31/5025 ; A61K45/06 ; C07D417/04
Abstract:
Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
Public/Granted literature
- US20140088110A1 FUSED BICYCLIC IMIDAZOLES Public/Granted day:2014-03-27
Information query
